XTX Topco’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
Other funds holding FHTX
EC
SL
XTX Topco's FHTX Position: Q3 2026 in Review
XTX Topco opened a new position in Foghorn Therapeutics (FHTX) in Q3 2026: 11,043 shares worth $39.4K. The stake represents ﹤0.01% of the portfolio and ranks #3579 among its holdings. This is a return to the name: XTX Topco previously reported a position in FHTX as recently as Q4 2025.
XTX Topco first reported a position in FHTX in Q2 2022 and has held it in 5 quarters since. The position peaked at $156K in Q2 2022. 122 funds tracked by Wall St. Rank hold FHTX as of Q3 2026.
- XTX Topco held 11,043 shares of Foghorn Therapeutics worth $39.4K as of Q3 2026.
- Foghorn Therapeutics was a new XTX Topco position in Q3 2026.
- Foghorn Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q3 2026, its #3579 holding.
- XTX Topco first reported a position in Foghorn Therapeutics in Q2 2022 and has held it in 5 quarters since.
- XTX Topco's Foghorn Therapeutics position peaked at $156K in Q2 2022.
- 122 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q3 2026.
Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.